339 related articles for article (PubMed ID: 37864255)
1. Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits.
Godfrey RK; Alsop E; Bjork RT; Chauhan BS; Ruvalcaba HC; Antone J; Gittings LM; Michael AF; Williams C; Hala'ufia G; Blythe AD; Hall M; Sattler R; Van Keuren-Jensen K; Zarnescu DC
Acta Neuropathol Commun; 2023 Oct; 11(1):168. PubMed ID: 37864255
[TBL] [Abstract][Full Text] [Related]
2. TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6.
Lehmkuhl EM; Loganathan S; Alsop E; Blythe AD; Kovalik T; Mortimore NP; Barrameda D; Kueth C; Eck RJ; Siddegowda BB; Joardar A; Ball H; Macias ME; Bowser R; Van Keuren-Jensen K; Zarnescu DC
Acta Neuropathol Commun; 2021 Mar; 9(1):52. PubMed ID: 33762006
[TBL] [Abstract][Full Text] [Related]
3. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD.
Kumar S; Phaneuf D; Cordeau P; Boutej H; Kriz J; Julien JP
Mol Neurodegener; 2021 Jan; 16(1):1. PubMed ID: 33413517
[TBL] [Abstract][Full Text] [Related]
4. C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD.
Ervilha Pereira P; Schuermans N; Meylemans A; LeBlanc P; Versluys L; Copley KE; Rubien JD; Altheimer C; Peetermans M; Debackere E; Vanakker O; Janssens S; Baets J; Verhoeven K; Lammens M; Symoens S; De Paepe B; Barmada SJ; Shorter J; De Bleecker JL; Bogaert E; Dermaut B
Acta Neuropathol; 2023 Jun; 145(6):793-814. PubMed ID: 37000196
[TBL] [Abstract][Full Text] [Related]
5. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
6. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy.
Khalil B; Chhangani D; Wren MC; Smith CL; Lee JH; Li X; Puttinger C; Tsai CW; Fortin G; Morderer D; Gao J; Liu F; Lim CK; Chen J; Chou CC; Croft CL; Gleixner AM; Donnelly CJ; Golde TE; Petrucelli L; Oskarsson B; Dickson DW; Zhang K; Shorter J; Yoshimura SH; Barmada SJ; Rincon-Limas DE; Rossoll W
Mol Neurodegener; 2022 Dec; 17(1):80. PubMed ID: 36482422
[TBL] [Abstract][Full Text] [Related]
7. TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43.
Godoy-Corchuelo JM; Ali Z; Brito Armas JM; Martins-Bach AB; García-Toledo I; Fernández-Beltrán LC; López-Carbonero JI; Bascuñana P; Spring S; Jimenez-Coca I; Muñoz de Bustillo Alfaro RA; Sánchez-Barrena MJ; Nair RR; Nieman BJ; Lerch JP; Miller KL; Ozdinler HP; Fisher EMC; Cunningham TJ; Acevedo-Arozena A; Corrochano S
Neurobiol Dis; 2024 Apr; 193():106437. PubMed ID: 38367882
[TBL] [Abstract][Full Text] [Related]
8. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
9. Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo.
Otte CG; Fortuna TR; Mann JR; Gleixner AM; Ramesh N; Pyles NJ; Pandey UB; Donnelly CJ
Neurobiol Dis; 2020 Dec; 146():105078. PubMed ID: 32927062
[TBL] [Abstract][Full Text] [Related]
10. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology.
Nana AL; Sidhu M; Gaus SE; Hwang JL; Li L; Park Y; Kim EJ; Pasquini L; Allen IE; Rankin KP; Toller G; Kramer JH; Geschwind DH; Coppola G; Huang EJ; Grinberg LT; Miller BL; Seeley WW
Acta Neuropathol; 2019 Jan; 137(1):27-46. PubMed ID: 30511086
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD.
Ueda T; Takeuchi T; Fujikake N; Suzuki M; Minakawa EN; Ueyama M; Fujino Y; Kimura N; Nagano S; Yokoseki A; Onodera O; Mochizuki H; Mizuno T; Wada K; Nagai Y
Acta Neuropathol Commun; 2024 Feb; 12(1):20. PubMed ID: 38311779
[TBL] [Abstract][Full Text] [Related]
12. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
[TBL] [Abstract][Full Text] [Related]
13. Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum.
Gittings LM; Alsop EB; Antone J; Singer M; Whitsett TG; Sattler R; Van Keuren-Jensen K
Acta Neuropathol; 2023 Sep; 146(3):433-450. PubMed ID: 37466726
[TBL] [Abstract][Full Text] [Related]
14. Endogenous retroviruses and TDP-43 proteinopathy form a sustaining feedback driving intercellular spread of Drosophila neurodegeneration.
Chang YH; Dubnau J
Nat Commun; 2023 Feb; 14(1):966. PubMed ID: 36810738
[TBL] [Abstract][Full Text] [Related]
15. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia.
Sidibé H; Khalfallah Y; Xiao S; Gómez NB; Fakim H; Tank EMH; Di Tomasso G; Bareke E; Aulas A; McKeever PM; Melamed Z; Destroimaisons L; Deshaies JE; Zinman L; Parker JA; Legault P; Tétreault M; Barmada SJ; Robertson J; Vande Velde C
Brain; 2021 Dec; 144(11):3461-3476. PubMed ID: 34115105
[TBL] [Abstract][Full Text] [Related]
17. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
[TBL] [Abstract][Full Text] [Related]
18. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Vanden Broeck L; Callaerts P; Dermaut B
Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
[TBL] [Abstract][Full Text] [Related]
19. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis.
Estes PS; Daniel SG; McCallum AP; Boehringer AV; Sukhina AS; Zwick RA; Zarnescu DC
Dis Model Mech; 2013 May; 6(3):721-33. PubMed ID: 23471911
[TBL] [Abstract][Full Text] [Related]
20. S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.
Pirie E; Oh CK; Zhang X; Han X; Cieplak P; Scott HR; Deal AK; Ghatak S; Martinez FJ; Yeo GW; Yates JR; Nakamura T; Lipton SA
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33692125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
